(Q60662415)
Statements
Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up (English)
Carol P Wilson
J J Strain
Tom G Trouton
Geraldine Horigan
John Purvis
scientific article published on 25 January 2012